Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0R2MO
|
|||
| Former ID |
DNC006364
|
|||
| Drug Name |
2-oxoguaia-1,4,11(13)-trien-12,8alpha-olide
|
|||
| Synonyms |
CHEMBL191179
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C15H16O3
|
|||
| Canonical SMILES |
CC1CC2C(CC3C1=CC(=O)C3=C)C(=C)C(=O)O2
|
|||
| InChI |
1S/C15H16O3/c1-7-4-14-12(9(3)15(17)18-14)5-11-8(2)13(16)6-10(7)11/h6-7,11-12,14H,2-5H2,1H3/t7-,11-,12+,14+/m0/s1
|
|||
| InChIKey |
RVBPAMCSEVHKLO-LWZBDFBTSA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Development of a structural model for NF-kappaB inhibition of sesquiterpene lactones using self-organizing neural networks. J Med Chem. 2006 Apr 6;49(7):2241-52. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.